Position in SVTR
Snapshot 2026-10-20- Startup SignalsTop 50%↓20
- Life SciencesTop 50%↓2
- Healthcare ServicesTop 50%↓1
About
Founded in 2021 and based in San Francisco, Abby Care trains and certifies family members as paid caregivers, acting as a licensed Medicaid provider, with AI-powered training, real-time care documentation and EVV compliance plus clinical oversight across eight US states.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Founders / core team
Investors
Funding history
- 2026-10-15Series C$82M
Investors · Transformation Capital、CVS Health Ventures、Frist Cressey Ventures、Pivotal Ventures、Khosla Ventures、Thrive Capital、Sequoia Capital
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Abby Care
Founded in 2021 and based in San Francisco, Abby Care trains and certifies family members as paid caregivers, acting as a licensed Medicaid provider, with AI-powered training, real-time care documentation and EVV compliance plus clinical oversight across eight US states.
Series C · $117M · 2026-10
$117M
United States
BusinessLatest roundTotal raisedDate- Pomelo Care
Pomelo Care is a New York-based virtual maternity and family health company founded in 2021, delivering 24/7 virtual clinical care across preconception, pregnancy, postpartum and newborn stages through health plans, employers and Medicaid organizations, covering more than 25 million lives. Its intelligent care platform embeds evidence-based pathways and predictive analytics into clinician workflows to surface and update patient risks.
Series C · $171M · 2026-01 · Valuation $1.7B
$171MValuation $1.7B - Sage
Sage, founded in 2020 in New York, USA, builds an AI care platform for senior living and skilled nursing facilities, helping care teams identify risks earlier and reduce health deterioration.
Series C · $124M · 2026-03
$124M - Inspiren
Inspiren, founded in 2016 in New York, USA, provides AI-driven safety and emergency response systems for senior living communities.
Series C · $225M · 2026-09 · Valuation $500M
$225MValuation $500M
China
BusinessLatest roundTotal raisedDate- 格式塔科技
Gestalt Technology, founded in 2026 in Chengdu, develops and applies ultrasound-based brain-computer interface technology.
Angel · $80M · 2026-07
$80M - Drug Farm
Innovative-drug developer using genetics and AI to discover first-in-class targets
Series D+ · $55M · 2026-07
$55M - Purui Intelligence
Purui Chuangzhi is a technology company that uses AI to transform pharmaceutical clinical trials, offering an end-to-end intelligent clinical trial platform featuring automated data flow, AI-driven decision-making, and built-in compliance throughout. The company has served nearly 300 domestic and international pharmaceutical enterprises and completed close to 600 Phase 1-3 registration and real-world study projects.
Series A · $14M · 2026-06
$14M
Europe
BusinessLatest roundTotal raisedDate- Voize
Voize, founded in 2020 in Potsdam, Germany, provides an AI-powered mobile app that enables care workers to document patient information via voice input, automatically generating structured reports.
Series A · $59M · 2025-11
$59M - Recare
Recare, founded in 2017 in Berlin, uses AI to automate and coordinate hospital discharge and post-acute care transition workflows.
$44M · 2026-02
$44M - Tandem Health
Tandem Health, founded in 2023 in Sweden, develops AI-powered software that helps healthcare providers by automatically generating medical records. The platform leverages GPT-4 and OpenAI's Whisper speech recognition technology, with adaptations for Swedish medical terminology.
Series B · $160M · 2026-09
$160M
Other / unspecified
BusinessLatest roundTotal raisedDate- Even Healthcare
Even Healthcare is a Bengaluru-based managed care company offering subscription memberships that integrate primary and secondary care through owned clinics, its own hospitals and partner facilities, coordinating preventive care with insurers to shift incentives from fee-for-service volume to patient outcomes.
Series B · $120M · 2026-10 · Valuation $300M
$120MValuation $300M - Craif
Craif, founded in 2018 in Tokyo, detects cancer at early stages using urine-based microRNA biomarkers and AI.
Series D+ · $88M · 2026-08
$88M - Heidi Health
Heidi Health (formerly Oscer), founded in 2019 in Melbourne, Australia, reduces administrative burden on physicians by using AI to convert consultation recordings into medical histories, referral letters, billing forms, and other clinical documents.
Series C · $437M · 2026-09 · Valuation $900M
$437MValuation $900M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
39 Life Sciences deals in the last 24 months · 14 at a nearby stage · 35 in 硅谷
Request intro →Y Combinator
38 Life Sciences deals in the last 24 months · 10 at a nearby stage · 31 in 硅谷
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 12 at a nearby stage · 22 in 硅谷
Request intro →Lightspeed
16 Life Sciences deals in the last 24 months · 11 at a nearby stage · 14 in 硅谷
Request intro →Insight Partners
14 Life Sciences deals in the last 24 months · 4 at a nearby stage · 13 in 硅谷
Request intro →Kleiner Perkins
14 Life Sciences deals in the last 24 months · 10 at a nearby stage · 14 in 硅谷
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.